Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.
Sarapa N, Britto MR, Cotton B, Cox SR, Francom SF, Jin N, Polasek ED, Sainati SM, Crosby-Sessoms SL, Fleishaker JC.
Sarapa N, et al. Among authors: polasek ed.
J Clin Pharmacol. 2003 Sep;43(9):974-82. doi: 10.1177/0091270003257220.
J Clin Pharmacol. 2003.
PMID: 12971029
Clinical Trial.